trending Market Intelligence /marketintelligence/en/news-insights/trending/uQYl01rMSuig6VwX44B0lw2 content esgSubNav
In This List

Stellar Biotechnologies expands board

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery


Stellar Biotechnologies expands board

Stellar Biotechnologies Inc. added Charles Olson and Paul Chun to its board of directors.

Olson is Anthera Pharmaceuticals Inc.'s chief technology officer and a biotechnology consultant for Compass Biotechnology LLC. He has been a member of Stellar's scientific advisory board since June 2014.

Chun is managing partner and founder of life sciences-focused advisory company Eldred Advisors LLC.